GE HealthCare Technologies Inc. (GEHC)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | ||
|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 1,993,000 | 1,675,000 | 1,580,000 | 1,570,000 | 1,568,000 | 1,719,000 |
| Total stockholders’ equity | US$ in thousands | 8,446,000 | 8,317,000 | 7,801,000 | 7,408,000 | 7,133,000 | 7,131,000 |
| ROE | 23.60% | 20.14% | 20.25% | 21.19% | 21.98% | 24.11% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,993,000K ÷ $8,446,000K
= 23.60%
The return on equity (ROE) of GE HealthCare Technologies Inc. has shown a generally positive trend over the periods presented. ROE stood at 24.11% as of September 30, 2023, indicating that for every dollar of shareholders' equity, the company generated a return of 24.11%. While there was a slight decrease in ROE to 21.98% by December 31, 2023, the metric remained above 20%, reflecting healthy profitability relative to shareholders' investments.
Subsequently, ROE experienced a further dip to 21.19% by March 31, 2024, and continued the declining trend to 20.25% by June 30, 2024. Despite these decreases, the metric still indicates efficient utilization of equity to generate profits. This was followed by a marginal reduction to 20.14% by September 30, 2024, suggesting the company's ability to sustain returns above the 20% mark.
The most notable increase in ROE occurred by December 31, 2024, rising to 23.60%. This upturn can be seen as a positive sign, indicating an improvement in the company's profitability and efficiency in utilizing shareholders' equity. Overall, while there were fluctuations in ROE over the periods analyzed, GE HealthCare Technologies Inc. has generally maintained a solid performance in terms of generating returns for its shareholders.
Peer comparison
Dec 31, 2024